focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Annual Financial Report

4 Apr 2024 13:55

RNS Number : 3746J
Integrated Diagnostics Holdings PLC
04 April 2024
 

Integrated Diagnostics Holdings plc

 (the "Company")

 

Annual Financial Report

Following the announcement on 28 March 2024 of its full year results for the year ended 31 December 2023 (RNS number: 6093I), the Company announces that it has published the 2023 Annual Report and Accounts ("2023 Annual Report") on the Company's website: https://investors.idhcorp.com/en/reports-and-presentations.

 

In accordance with Listing Rule 14.3.6, the 2023 Annual Report has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Company confirms that, in compliance with DTR 6.3.5 R (1A), the regulated information required under DTR 6.3.5, is available in unedited full text within the 2023 Annual Report available on the National Storage Mechanism and in compliance with DTR 6.3.5 (3) is available on the Company's website (see above).

  

 For further information please contact:

 

Integrated Diagnostics Holdings plc

 

 

Tarek Yehia

Investor Relations Director

+20(0)1068826678

Company Secretary

Link Company Matters Limited

IDHLondon@linkgroup.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSSLFELELSEIL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.